Advertisement
INSP vs MASI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSP is a Buy and MASI is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INSP’s FA Score shows that 0 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).
- INSP’s FA Score: 0 green, 5 red.
- MASI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INSP’s TA Score shows that 4 TA indicator(s) are bullish while MASI’s TA Score has 6 bullish TA indicator(s).
- INSP’s TA Score: 4 bullish, 5 bearish.
- MASI’s TA Score: 6 bullish, 4 bearish.
Price Growth
INSP (@Medical/Nursing Services) experienced а -11.85% price change this week, while MASI (@Medical/Nursing Services) price change was +0.88% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.35%. For the same industry, the average monthly price growth was -0.90%, and the average quarterly price growth was +13.54%.
Reported Earning Dates
INSP is expected to report earnings on Feb 11, 2026.
MASI is expected to report earnings on Mar 03, 2026.
Industries' Descriptions
@Medical/Nursing Services (-3.35% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| INSP | MASI | INSP / MASI | |
| Capitalization | 1.98B | 7.34B | 27% |
| EBITDA | 64.7M | -73.3M | -88% |
| Gain YTD | -21.826 | 6.974 | -313% |
| P/E Ratio | 46.73 | 116.80 | 40% |
| Revenue | 883M | 2.18B | 40% |
| Total Cash | 323M | 312M | 104% |
| Total Debt | 32.6M | 586M | 6% |
INSP | MASI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 78 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | 89 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 97 | |
PRICE GROWTH RATING 1..100 | 85 | 60 | |
P/E GROWTH RATING 1..100 | 99 | 17 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INSP's Valuation (71) in the Medical Specialties industry is in the same range as MASI (89). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.
INSP's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MASI (100). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.
INSP's SMR Rating (80) in the Medical Specialties industry is in the same range as MASI (97). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.
MASI's Price Growth Rating (60) in the Medical Specialties industry is in the same range as INSP (85). This means that MASI’s stock grew similarly to INSP’s over the last 12 months.
MASI's P/E Growth Rating (17) in the Medical Specialties industry is significantly better than the same rating for INSP (99). This means that MASI’s stock grew significantly faster than INSP’s over the last 12 months.
| INSP | MASI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 59% |
| Stochastic ODDS (%) | 2 days ago 83% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 78% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 67% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 68% |
| Advances ODDS (%) | 8 days ago 84% | 2 days ago 65% |
| Declines ODDS (%) | 2 days ago 77% | 7 days ago 69% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 66% |
| Aroon ODDS (%) | 2 days ago 82% | 2 days ago 75% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NAMAX | 15.65 | 0.18 | +1.16% |
| Columbia Select Mid Cap Value Instl | |||
| DRLIX | 8.78 | 0.04 | +0.46% |
| BNY Mellon Developed Markets RE Scs - I | |||
| RMORX | 26.45 | -0.11 | -0.41% |
| Victory RS Mid Cap Growth R6 | |||
| PEQUX | 19.32 | -0.15 | -0.77% |
| Putnam Focused International Equity A | |||
| VAFNX | 30.34 | -0.54 | -1.75% |
| Invesco American Franchise R5 | |||
INSP and
Correlation & Price change
A.I.dvisor indicates that over the last year, INSP has been loosely correlated with BRKR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then BRKR could also see price increases.
| Ticker / NAME | Correlation To INSP | 1D Price Change % | ||
|---|---|---|---|---|
| INSP | 100% | -1.84% | ||
| BRKR - INSP | 42% Loosely correlated | -2.49% | ||
| AVNS - INSP | 41% Loosely correlated | -0.37% | ||
| MASI - INSP | 38% Loosely correlated | +0.51% | ||
| AZTA - INSP | 37% Loosely correlated | -1.65% | ||
| ENOV - INSP | 36% Loosely correlated | -1.71% | ||
More | ||||
MASI and
Correlation & Price change
A.I.dvisor indicates that over the last year, MASI has been loosely correlated with SYK. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then SYK could also see price increases.
| Ticker / NAME | Correlation To MASI | 1D Price Change % | ||
|---|---|---|---|---|
| MASI | 100% | +0.51% | ||
| SYK - MASI | 51% Loosely correlated | -1.99% | ||
| BSX - MASI | 48% Loosely correlated | -0.27% | ||
| VCYT - MASI | 47% Loosely correlated | -1.10% | ||
| ISRG - MASI | 46% Loosely correlated | -3.59% | ||
| ENOV - MASI | 44% Loosely correlated | -1.71% | ||
More | ||||